A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodology

BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive thoracic malignancy with a poor prognosis. Systemic immunotherapy is an effective frontline treatment for MPM, and there is a scientific rationale supporting the possible efficacy of local, i.e. intra-pleural immune modulators. Trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Bibby, Anna C., Zahan-Evans, Natalie, Keenan, Emma, Comins, Charles, Harvey, John E., Day, Helen, Rahman, Najib M., Fallon, Janet E., Gooberman-Hill, Rachael, Maskell, Nick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440504/
https://www.ncbi.nlm.nih.gov/pubmed/36057634
http://dx.doi.org/10.1186/s40814-022-01156-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440504/
https://www.ncbi.nlm.nih.gov/pubmed/36057634
http://dx.doi.org/10.1186/s40814-022-01156-3

Ejemplares similares